美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

11.33

-0.1400-1.22%

盤後：11.330.00000.00%16:05 EDT

成交量：7.98萬

成交額：92.75萬

市值：4.14億

市盈率：-3.00

高：12.31

開：11.76

低：11.27

收：11.47

資料載入中...

總覽公司新聞公告

Rapport Therapeutics, Inc.盤中異動大幅上漲7.32%報12.31美元

Rapport Therapeutics, Inc.盤中異動股價大漲5.20%報11.63美元

Rapport Therapeutics, Inc.盤中異動急速上漲7.06%報11.37美元

Rapport Therapeutics, Inc.盤中異動股價大跌5.41%報10.50美元

Rapport Therapeutics, Inc.盤中異動下午盤大幅下挫5.01%

Rapport Therapeutics, Inc.盤中異動股價大漲6.17%報11.02美元

Rapport Therapeutics, Inc.盤中異動下午盤急速下跌5.18%

Rapport Therapeutics, Inc.盤中異動快速上漲5.51%報9.77美元

Rapport Therapeutics, Inc.盤中異動快速上漲5.64%報9.12美元

Rapport Therapeutics, Inc.盤中異動早盤急速下挫7.00%

Rapport Therapeutics獲摩根大通證券公司首次覆蓋，給予優於大市評級, 目標價28.00美元。

Rapport Therapeutics, Inc.盤中異動早盤股價大漲12.51%

Rapport Therapeutics, Inc.盤中異動股價大漲5.01%報9.44美元

Rapport Therapeutics, Inc.盤中異動股價大跌6.98%報7.93美元

Rapport Therapeutics, Inc.2024財年實現淨利潤-78.31百萬美元，同比減少125.09%

Rapport Therapeutics, Inc.盤中異動股價大漲5.32%報8.71美元

Rapport Therapeutics 2024財年第四季度每股虧損$(0.57)，優於預期$(0.62)，年末現金、現金等價物和短期投資達3.053億美元，預計可支持運營至2026年底

Rapport Therapeutics, Inc.盤中異動股價大跌5.24%報8.14美元

Rapport Therapeutics, Inc.盤中異動快速跳水5.54%

Rapport Therapeutics, Inc.盤中異動快速拉昇5.01%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RAPP/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":11.33,"timestamp":1746216000000,"preClose":11.47,"halted":0,"volume":79809,"hourTrading":{"tag":"盘后","latestPrice":11.33,"preClose":11.33,"latestTime":"16:05 EDT","volume":681,"amount":7715.73,"timestamp":1746216310622},"delay":0,"floatShares":14750261,"shares":36496437,"eps":-3.775953,"marketStatus":"休市中","change":-0.14,"latestTime":"05-02 16:00:00 EDT","open":11.76,"high":12.3101,"low":11.27,"amount":927515.597087,"amplitude":0.09068,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.775953,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":11.47,"preHourTrading":{"tag":"盘前","latestPrice":11.47,"preClose":11.47,"latestTime":"04:22 EDT","volume":4,"amount":46.32,"timestamp":1746174148162},"postHourTrading":{"tag":"盘后","latestPrice":11.33,"preClose":11.33,"latestTime":"16:05 EDT","volume":681,"amount":7715.73,"timestamp":1746216310622},"volumeRatio":0.5211982292158605,"impliedVol":0.7198,"impliedVolPercentile":0.5545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":14750261,"roa":"-22.07%","roe":"-35.09%","lyrEps":-3.775953,"volumeRatio":0.5211982292158605,"shares":36496437,"dividePrice":0,"high":12.3101,"amplitude":0.09068,"preClose":11.47,"low":11.27,"week52Low":6.43,"pbRate":"1.35","week52High":29.74,"institutionHeld":0,"latestPrice":11.33,"eps":-3.775953,"divideRate":0,"volume":79809,"delay":0,"ttmEps":-3.775953,"open":11.76,"prevYearClose":17.74,"prevWeekClose":10.62,"prevMonthClose":11.45,"prevQuarterClose":10.03,"fiveDayClose":10.62,"twentyDayClose":8.52,"sixtyDayClose":17.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532767844","title":"Rapport Therapeutics, Inc.盤中異動 大幅上漲7.32%報12.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532767844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532767844?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 21:33","pubTimestamp":1746192814,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时33分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨7.32%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为206.19%、155.87%、60.03%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、37.45%、18.34%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213335974d6531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213335974d6531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RAPP","BK4007","LENZ"],"gpt_icon":0},{"id":"2532619330","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲5.20%報11.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532619330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532619330?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 01:53","pubTimestamp":1746035610,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时53分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨5.20%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Abeona Therapeutics Inc.涨幅较大，Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃，换手率分别为163.79%、37.06%、35.99%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为64.00%、37.52%、34.25%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501015330974bd277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501015330974bd277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RAPP","BK4007","LENZ"],"gpt_icon":0},{"id":"2530875132","title":"Rapport Therapeutics, Inc.盤中異動 急速上漲7.06%報11.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530875132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530875132?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:43","pubTimestamp":1745847829,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨7.06%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1601.08%、344.16%、66.30%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Protara Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为27.39%、22.69%、22.50%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214349a46a91b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214349a46a91b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RAPP"],"gpt_icon":0},{"id":"2530139163","title":"Rapport Therapeutics, Inc.盤中異動 股價大跌5.41%報10.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530139163?lang=zh_tw&edition=fundamental","pubTime":"2025-04-26 01:39","pubTimestamp":1745602790,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日01时39分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下跌5.41%。截至发稿，该股报10.50美元/股，成交量2.4875万股，换手率0.07%，振幅6.67%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426013950974552ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426013950974552ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2530966293","title":"Rapport Therapeutics, Inc.盤中異動 下午盤大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530966293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530966293?lang=zh_tw&edition=fundamental","pubTime":"2025-04-25 02:10","pubTimestamp":1745518244,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时10分，Rapport Therapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021045a465b760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021045a465b760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2529878175","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲6.17%報11.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529878175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529878175?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 21:50","pubTimestamp":1745329813,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时50分，Rapport Therapeutics, Inc.股票出现波动，股价急速拉升6.17%。截至发稿，该股报11.02美元/股，成交量3840股，换手率0.01%，振幅4.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422215013a6c3df4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422215013a6c3df4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2527273425","title":"Rapport Therapeutics, Inc.盤中異動 下午盤急速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527273425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527273425?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 01:30","pubTimestamp":1744738231,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日01时30分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌5.18%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为1396.53%、965.04%、253.86%，振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.，振幅分别为171.53%、97.08%、91.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041601303194d65941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041601303194d65941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2527136271","title":"Rapport Therapeutics, Inc.盤中異動 快速上漲5.51%報9.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527136271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527136271?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 00:44","pubTimestamp":1744649074,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日00时44分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.51%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.02%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为709.10%、650.15%、330.08%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为72.35%、48.91%、45.11%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415004434a458b422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415004434a458b422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2526113276","title":"Rapport Therapeutics, Inc.盤中異動 快速上漲5.64%報9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526113276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526113276?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 01:49","pubTimestamp":1744393759,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时49分，Rapport Therapeutics, Inc.股票出现波动，股价快速拉升5.64%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。消息层面，截至01时49分，《Rapport Therapeutics获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价28.00美元。》资讯为影响Rapport Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014919aa2c6d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014919aa2c6d28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RAPP","LENZ"],"gpt_icon":0},{"id":"2526459360","title":"Rapport Therapeutics, Inc.盤中異動 早盤急速下挫7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526459360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526459360?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:31","pubTimestamp":1744205510,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时31分，Rapport Therapeutics, Inc.股票出现异动，股价快速跳水7.00%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。消息层面，截至21时31分，《Rapport Therapeutics获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价28.00美元。》资讯为影响Rapport Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921315097334cde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921315097334cde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","RAPP"],"gpt_icon":0},{"id":"2526846250","title":"Rapport Therapeutics獲摩根大通證券公司首次覆蓋，給予優於大市評級, 目標價28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2526846250","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526846250?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 01:04","pubTimestamp":1744131841,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics(RAPP.US)获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040901060894cfc2dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040901060894cfc2dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP"],"gpt_icon":0},{"id":"2525781980","title":"Rapport Therapeutics, Inc.盤中異動 早盤股價大漲12.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525781980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525781980?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 21:36","pubTimestamp":1744119399,"startTime":"0","endTime":"0","summary":"北京时间2025年04月08日21时36分，Rapport Therapeutics, Inc.股票出现异动，股价快速拉升12.51%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Onconetix, Inc.、Cormedix Inc.涨幅较大，Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Naya Biosciences, Inc.较为活跃，换手率分别为831.00%、743.54%、43.40%，振幅较大的相关个股有Onconetix, Inc.、60 Degrees Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为33.61%、27.80%、22.32%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213639a6b42d42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408213639a6b42d42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2525024502","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲5.01%報9.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525024502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525024502?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 00:29","pubTimestamp":1744043349,"startTime":"0","endTime":"0","summary":"北京时间2025年04月08日00时29分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Cingulate Inc C/Wts 10/12/2026 、Artiva Biotherapeutics, Inc.涨幅较大，Transcode Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为160.47%、91.19%、72.19%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Artiva Biotherapeutics, Inc.、Abvc Biopharma, Inc.，振幅分别为116.42%、113.11%、81.36%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408002909a6b2e74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408002909a6b2e74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2524678583","title":"Rapport Therapeutics, Inc.盤中異動 股價大跌6.98%報7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524678583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524678583?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 21:33","pubTimestamp":1743773628,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日21时33分，Rapport Therapeutics, Inc.股票出现波动，股价大幅下挫6.98%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Impact Biomedical, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为1818.73%、402.24%、272.45%，振幅较大的相关个股有Fate Therapeutics, Inc.、Fortress Biotech, Inc.、Ionis Pharmaceuticals, Inc.，振幅分别为102.94%、100.00%、99.91%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404213348a44dd98e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404213348a44dd98e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","RAPP"],"gpt_icon":0},{"id":"2519216588","title":"Rapport Therapeutics, Inc.2024財年實現淨利潤-78.31百萬美元，同比減少125.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519216588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519216588?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 16:00","pubTimestamp":1741939228,"startTime":"0","endTime":"0","summary":"3月14日，Rapport Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-78.31百万美元，同比减少125.09%；其中营业收入为0.00美元，每股基本收益为-2.14美元。从资产负债表来看，Rapport Therapeutics, Inc.总负债9.51百万美元，其中短期债务737000.00美元，资产负债比为0.34，流动比率为0.36。机构评级：截至2025年3月14日，当前有3家机构对Rapport Therapeutics, Inc.目标价做出预测，其中目标均价为37.33美元，其中最低目标价为35.00美元，最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164533a1dc78e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164533a1dc78e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP"],"gpt_icon":0},{"id":"2518729748","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲5.32%報8.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518729748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518729748?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 23:50","pubTimestamp":1741708255,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日23时50分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.32%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.87%。其相关个股中，Syros Pharmaceuticals, Inc.、2Seventy Bio, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Syros Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为2186.96%、766.81%、272.50%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Surrozen Inc C/Wts 01/08/2031 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为160.37%、144.00%、90.27%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031123505596418070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031123505596418070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"1126656451","title":"Rapport Therapeutics 2024財年第四季度每股虧損$(0.57)，優於預期$(0.62)，年末現金、現金等價物和短期投資達3.053億美元，預計可支持運營至2026年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1126656451","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126656451?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 19:43","pubTimestamp":1741693381,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics 报告季度每股亏损$，优于分析师预期的$，超出8.06%。与去年同期每股亏损$相比，这是一个92.88%的增长。以上内容来自Benzinga Earnings专栏，原文如下：Rapport $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 8.06 percent. This is a 92.88 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","LENZ"],"gpt_icon":0},{"id":"2518274695","title":"Rapport Therapeutics, Inc.盤中異動 股價大跌5.24%報8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518274695?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Rapport Therapeutics, Inc.股票出现波动，股价急速下跌5.24%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3087.26%、661.78%、287.22%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2517163165","title":"Rapport Therapeutics, Inc.盤中異動 快速跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517163165?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:31","pubTimestamp":1741271504,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Rapport Therapeutics, Inc.股票出现波动，股价快速下挫5.54%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为946.46%、104.14%、48.84%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223145abeb7784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223145abeb7784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2517094698","title":"Rapport Therapeutics, Inc.盤中異動 快速拉昇5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517094698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517094698?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 23:09","pubTimestamp":1741187351,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时09分，Rapport Therapeutics, Inc.股票出现波动，股价急速拉升5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.59%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230911a260d3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230911a260d3b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"盤前","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2024-11-07","symbol":"RAPP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2025-05-02","current":-5.345807,"percent":0.782609,"low":-18.456468,"twenty":-13.651898,"median":-10.548248,"eighty":-5.303861,"high":-1.238107,"avg":-9.996797,"sd":4.10499,"marketCap":418614132},"quantilePoints":[{"date":"2024-06-07","current":-11.721364,"twenty":-11.721364,"median":-11.721364,"eighty":-11.721364,"marketCap":601399769},{"date":"2024-06-14","current":-15.892791,"twenty":-16.325792,"median":-15.672154,"eighty":-13.81742,"marketCap":815427333},{"date":"2024-06-21","current":-15.811683,"twenty":-18.036085,"median":-15.892791,"eighty":-15.139866,"marketCap":811265816},{"date":"2024-06-28","current":-16.346343,"twenty":-18.021611,"median":-15.892791,"eighty":-15.672154,"marketCap":838698159},{"date":"2024-07-05","current":-16.610109,"twenty":-18.028848,"median":-16.581593,"eighty":-15.672154,"marketCap":852231448},{"date":"2024-07-12","current":-18.456468,"twenty":-18.064817,"median":-16.682383,"eighty":-15.783777,"marketCap":946964471},{"date":"2024-07-15","current":-18.299635,"twenty":-18.092899,"median":-16.754656,"eighty":-15.811683,"marketCap":938917651},{"date":"2024-08-02","current":-14.614044,"twenty":-18.085878,"median":-16.682383,"eighty":-15.70006,"marketCap":749817368},{"date":"2024-08-09","current":-10.772462,"twenty":-18.050559,"median":-16.581593,"eighty":-14.719551,"marketCap":678859041},{"date":"2024-08-16","current":-11.828814,"twenty":-17.877609,"median":-15.852237,"eighty":-12.152035,"marketCap":745428193},{"date":"2024-08-23","current":-12.310557,"twenty":-17.253126,"median":-15.672154,"eighty":-12.113216,"marketCap":775786652},{"date":"2024-08-30","current":-11.492174,"twenty":-17.046391,"median":-14.856424,"eighty":-11.831136,"marketCap":724213848},{"date":"2024-09-06","current":-12.316361,"twenty":-16.995064,"median":-14.477739,"eighty":-11.828814,"marketCap":776152417},{"date":"2024-09-13","current":-10.975607,"twenty":-16.754656,"median":-13.041877,"eighty":-11.712731,"marketCap":691660801},{"date":"2024-09-20","current":-11.75336,"twenty":-16.610109,"median":-12.73716,"eighty":-11.45735,"marketCap":740673254},{"date":"2024-09-27","current":-11.915876,"twenty":-16.610109,"median":-12.415031,"eighty":-11.492174,"marketCap":750914662},{"date":"2024-10-04","current":-10.644772,"twenty":-16.581593,"median":-12.319263,"eighty":-11.45735,"marketCap":670812221},{"date":"2024-10-11","current":-11.846226,"twenty":-16.346343,"median":-12.304752,"eighty":-11.439937,"marketCap":746525487},{"date":"2024-10-18","current":-16.28058,"twenty":-16.346343,"median":-12.319263,"eighty":-11.45735,"marketCap":1025969618},{"date":"2024-10-25","current":-14.411651,"twenty":-16.28058,"median":-12.415031,"eighty":-11.492174,"marketCap":908193427},{"date":"2024-10-31","current":-15.578281,"twenty":-15.970349,"median":-12.705237,"eighty":-11.650047,"marketCap":981712105},{"date":"2024-11-08","current":-13.694662,"twenty":-15.827905,"median":-12.870655,"eighty":-11.708088,"marketCap":983906693},{"date":"2024-11-15","current":-11.189913,"twenty":-15.754653,"median":-12.798103,"eighty":-11.650047,"marketCap":803950524},{"date":"2024-11-22","current":-11.464825,"twenty":-15.685802,"median":-12.664608,"eighty":-11.434133,"marketCap":823701811},{"date":"2024-11-29","current":-11.627735,"twenty":-15.672154,"median":-12.397619,"eighty":-11.395825,"marketCap":835406277},{"date":"2024-12-06","current":-10.319361,"twenty":-15.61583,"median":-12.322165,"eighty":-11.357915,"marketCap":741404783},{"date":"2024-12-13","current":-9.677901,"twenty":-15.33799,"median":-12.307654,"eighty":-11.16344,"marketCap":695318447},{"date":"2024-12-20","current":-9.092441,"twenty":-15.121845,"median":-12.218286,"eighty":-11.007144,"marketCap":653255522},{"date":"2024-12-27","current":-9.815356,"twenty":-15.075412,"median":-12.095804,"eighty":-10.933817,"marketCap":705194090},{"date":"2025-01-03","current":-9.362262,"twenty":-15.053587,"median":-12.072587,"eighty":-10.78291,"marketCap":672641044},{"date":"2025-01-10","current":-8.4968,"twenty":-15.021085,"median":-11.886855,"eighty":-10.451725,"marketCap":610461067},{"date":"2025-01-17","current":-6.368782,"twenty":-15.009476,"median":-11.834618,"eighty":-10.309179,"marketCap":457571477},{"date":"2025-01-24","current":-7.264789,"twenty":-14.781954,"median":-11.796891,"eighty":-9.793974,"marketCap":521946041},{"date":"2025-01-31","current":-8.476436,"twenty":-14.660068,"median":-11.755009,"eighty":-9.580154,"marketCap":608998009},{"date":"2025-02-07","current":-8.527345,"twenty":-14.639173,"median":-11.73446,"eighty":-9.397898,"marketCap":612655654},{"date":"2025-02-14","current":-8.028432,"twenty":-14.630244,"median":-11.689515,"eighty":-9.145387,"marketCap":576810726},{"date":"2025-02-21","current":-6.618238,"twenty":-14.619747,"median":-11.627735,"eighty":-9.042041,"marketCap":475493941},{"date":"2025-02-28","current":-5.467683,"twenty":-14.492608,"median":-11.461087,"eighty":-8.488654,"marketCap":392831148},{"date":"2025-03-07","current":-4.11349,"twenty":-14.373344,"median":-11.410917,"eighty":-8.297234,"marketCap":295537772},{"date":"2025-03-14","current":-4.670008,"twenty":-14.343983,"median":-11.35537,"eighty":-8.022323,"marketCap":365694298},{"date":"2025-03-21","current":-4.716615,"twenty":-14.310432,"median":-11.296823,"eighty":-7.313662,"marketCap":369343942},{"date":"2025-03-28","current":-4.520866,"twenty":-14.209667,"median":-11.0932,"eighty":-7.051987,"marketCap":354015438},{"date":"2025-04-04","current":-3.970905,"twenty":-14.097067,"median":-11.027844,"eighty":-6.777076,"marketCap":310949643},{"date":"2025-04-11","current":-4.022172,"twenty":-13.848651,"median":-10.975607,"eighty":-6.460419,"marketCap":314964251},{"date":"2025-04-17","current":-4.54883,"twenty":-13.703476,"median":-10.88248,"eighty":-6.145798,"marketCap":356205225},{"date":"2025-04-25","current":-5.173362,"twenty":-13.694662,"median":-10.772462,"eighty":-5.351373,"marketCap":405110450},{"date":"2025-05-02","current":-5.345807,"twenty":-13.651898,"median":-10.548248,"eighty":-5.303861,"marketCap":418614132}],"updateTime":1746282477918}}}